Table of Contents
Journal of Amino Acids
Volume 2011 (2011), Article ID 265084, 10 pages
http://dx.doi.org/10.4061/2011/265084
Review Article

The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases

1Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan
2Department of Medicine (Neurology) and Deane Laboratory, Duke University Medical Center, Durham, NC 27710, USA
3Department of Bioorganic Medicinal Chemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto 606-8501, Japan
4Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
5Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012, Japan

Received 31 January 2011; Accepted 4 May 2011

Academic Editor: Andreas Wyttenbach

Copyright © 2011 H. Akiko Popiel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

H. Akiko Popiel, James R. Burke, Warren J. Strittmatter, et al., “The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases,” Journal of Amino Acids, vol. 2011, Article ID 265084, 10 pages, 2011. doi:10.4061/2011/265084